For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
0
views
20
references
 Top references
cited by
1
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      4,202
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Serotonin 5-HT 2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents

      Author(s): 1 , 2 , 3
      Publication date (Electronic):
      Journal: Expert Opinion on Drug Safety
      Publisher: Informa UK Limited

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

          Guy M. Goodwin, Scott Aaronson, Oscar Álvarez … (2022)
          Article 0 comments Cited 176 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies

            Kristoffer Andersen, Robin Carhart-Harris, David J Nutt … (2021)
            To conduct a systematic review of modern-era (post-millennium) clinical studies assessing the therapeutic effects of serotonergic psychedelics drugs for mental health conditions. Although the main focus was on efficacy and safety, study characteristics, duration of antidepressants effects across studies, and the role of the subjective drug experiences were also reviewed and presented.
            Article 0 comments Cited 93 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Drugs and valvular heart disease.

              Bryan Roth (2007)
              Article 0 comments Cited 36 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Title: Expert Opinion on Drug Safety
                Abbreviated Title: Expert Opinion on Drug Safety
                Publisher: Informa UK Limited
                ISSN (Print): 1474-0338
                ISSN (Electronic): 1744-764X
                Publication date Created: October 03 2023
                Publication date (Electronic): August 18 2023
                Publication date (Print): October 03 2023
                Volume: 22
                Issue: 10
                Pages: 881-883
                Affiliations
                [1 ]Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
                [2 ]Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
                [3 ]Brain and Cognition Discovery Foundation, Toronto, ON, Canada
                Article
                DOI: 10.1080/14740338.2023.2248883
                PubMed ID: 37581427
                SO-VID: c106dfa9-fc3c-49e0-8785-056662db991e
                Copyright © © 2023
                History

                Data availability:

                Comments

                Comment on this article

                scite_

                Similar content4,202

                See all similar

                Cited by1

                See all cited by

                Most referenced authors390

                See all reference authors